StockData

AVAI Bio, Inc. (AVAI) stock

AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.11−0.00 (-1.75%)

Close on Oct 19, 2026Market cap $17.24MP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026

Valuation

Market cap
$17.24M
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Net income
-$2.79M
EPS, diluted
$0.00
Book value per share
-$0.02
Diluted shares
154M

Trading

Previous close
$0.11
Open
$0.11
Day's range
$0.11 – $0.11
Volume
25,000
Average volume (20 days)
77,140

Market cap history

Month-end market cap since 2020, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodAVAIS&P 500DifferenceAVAI per yearS&P 500 per year
1 month-30.0%+0.6%−30.6 pts
3 months-25.2%+3.4%−28.6 pts
Year to date-70.5%+13.3%−83.8 pts
1 year-65.0%+16.6%−81.6 pts
3 years-88.8%+86.4%−175.2 pts-51.8%+23.1%
5 years-92.8%+81.9%−174.6 pts-40.9%+12.7%

Nine years at a glance

Fiscal years 2018 to 2026 and trailing twelve months, USD

Revenue

–

Gross profit

–

Operating income

-$1.81M

Net income

-$2.79M

EPS, diluted

$0.00
Reported periodTrailing twelve months

Press releases

Releases AVAI Bio filed with the SEC as exhibits to Form 8-K or 6-K

About AVAI Bio

Services-Computer Processing & Data Preparation

Avai Bio, Inc. develops and commercializes artificial intelligence solutions and provides information technology consulting services. The company focuses on machine learning systems and data integration, database management, and cloud services. Its primary technology assets include Avant! AI, an unsupervised and supervised learning model designed for data processing and reasoning, and Instant Fame, a platform facilitating digital art ratings and auctions. Additionally, the company offers Thy News, a mobile application that aggregates news feeds from various publishers for individual consumers. Through these offerings, Avai Bio serves enterprise organizations seeking artificial intelligence capabilities and end users of its digital media platforms.

Company profile, executives and history

AVAI Bio stock: common questions

What is AVAI Bio's stock price?

AVAI closed at $0.11 on Oct 19, 2026, down 1.75% on the day.

What is AVAI Bio's market cap?

AVAI Bio was worth $17.24M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is AVAI's P/E ratio?

AVAI Bio lost money over the twelve months to Jun 30, 2026 (diluted EPS $0.00), so it has no meaningful P/E ratio.

Does AVAI Bio pay a dividend?

No. AVAI Bio has not paid a cash dividend over the last twelve months.

How has AVAI stock performed over the past year?

Including dividends, AVAI returned -65.0% over the past year, against +16.6% for the S&P 500.

Who are AVAI Bio's competitors?

Companies most similar to AVAI Bio by business, industry and size include ELVX, VERI, INOD, RADC, SHAZ.

See a number that looks wrong?